https://www.selleckchem.com/pr....oducts/8-oh-dpat-8-h
04 ± 1.0 (p-value 0.046). Women taking estrogen had lower mean BMD at the lumbar spine 0.952 ± 0.086 g/cm2, compared to women not taking estrogen 1.023 ± 0.105 g/cm2 (p-value 0.038). Similar trends were seen at the total hip and femoral neck. Conclusion Low-dose estrogen supplementation in premenopausal women with CF was associated with lower BMD compared to no estrogen supplementation in a similar group of premenopausal young women with CF. Future studies are needed to investigate the optimal formulation, route of admi
Like
Comment
Share
